Pharmacokinetics of acebutolol after intravenous bolus administration.
作者信息
Roux A, Flouvat B, Chau N P, Letac B, Lucsko M
出版信息
Br J Clin Pharmacol. 1980 Feb;9(2):215-7. doi: 10.1111/j.1365-2125.1980.tb05837.x.
Abstract
摘要
相似文献
1
Pharmacokinetics of acebutolol after intravenous bolus administration.静脉推注醋丁洛尔后的药代动力学。
Br J Clin Pharmacol. 1980 Feb;9(2):215-7. doi: 10.1111/j.1365-2125.1980.tb05837.x.
2
Systemic bioavailability of acebutolol in man.醋丁洛尔在人体中的全身生物利用度。
Biopharm Drug Dispos. 1983 Jul-Sep;4(3):293-7. doi: 10.1002/bdd.2510040309.
3
Dose-dependent acebutolol disposition after oral administration.口服给药后醋丁洛尔的剂量依赖性处置。
Clin Pharmacol Ther. 1978 Nov;24(5):542-7. doi: 10.1002/cpt1978245542.
4
Observations on the pharmacokinetics of acebutolol.醋丁洛尔的药代动力学观察
Clin Pharmacol Ther. 1976 Apr;19(4):416-20. doi: 10.1002/cpt1976194416.
5
6
The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).盐酸醋丁洛尔单次口服给药（400毫克）后，以及多次口服给药期间和之后（400毫克，每日两次）在人体中的药代动力学。
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):103-14. doi: 10.1002/bdd.2510020202.
7
Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.醋丁洛尔和氢氯噻嗪单药及联合用药在人体中的药代动力学。
Eur J Clin Pharmacol. 1983;24(6):801-6. doi: 10.1007/BF00607091.
8
Circulatory effects of intravenous and oral acebutolol in acute myocardial infarction.静脉注射与口服醋丁洛尔对急性心肌梗死的循环系统影响
Clin Pharmacol Ther. 1985 Sep;38(3):266-72. doi: 10.1038/clpt.1985.169.
9
Acebutolol disposition after intravenous administration.静脉注射后醋丁洛尔的处置情况。
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):557-67. doi: 10.1002/cpt1977225part1557.
10
Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.肾功能损害患者中醋丁洛尔及其乙酰代谢物的血浆和尿液浓度。
N Z Med J. 1980 Apr 23;91(658):289-91.
引用本文的文献
1
Distribution Clearance: Significance and Underlying Mechanisms.分布清除：意义和潜在机制。
Pharm Res. 2024 Jul;41(7):1391-1400. doi: 10.1007/s11095-024-03738-7. Epub 2024 Jul 9.
2
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒：EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
3
Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.醋丁洛尔的主要代谢产物双醋洛尔的药代动力学和生物利用度。
Eur J Clin Pharmacol. 1981 Mar;19(4):287-92. doi: 10.1007/BF00562806.
4
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.醋丁洛尔。其药理学特性及在高血压、心绞痛和心律失常治疗中的疗效综述。
Drugs. 1985 Jun;29(6):531-69. doi: 10.2165/00003495-198529060-00003.
本文引用的文献
1
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.β肾上腺素能拮抗剂心得宁在人体的药代动力学研究。
Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26-9. doi: 10.1002/cpt197314126.
2
Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.人用选择性β1受体拮抗剂美托洛尔的药代动力学研究。
J Pharmacokinet Biopharm. 1974 Aug;2(4):347-64. doi: 10.1007/BF01061407.
3
[Acebutolol in arterial hypertension. Hemodynamic effects and effects on plasma renin].
Nouv Presse Med. 1975 Jan 4;4(1):21-2, 24-5, 26.
4
Acebutolol disposition after intravenous administration.静脉注射后醋丁洛尔的处置情况。
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):557-67. doi: 10.1002/cpt1977225part1557.
5
[Sensitive method for the determination of acebutolol and its N-acetyl metabolite in biological media by high performance liquid chromatography and fluorescence detection].[高效液相色谱-荧光检测法测定生物介质中醋丁洛尔及其N-乙酰代谢物的灵敏方法]
J Chromatogr. 1978 Dec 1;166(1):327-32. doi: 10.1016/s0021-9673(00)92284-2.
6
Cardiac and pulmonary effects of acebutolol.醋丁洛尔对心脏和肺部的影响。
Lancet. 1975 Jul 19;2(7925):89-93. doi: 10.1016/s0140-6736(75)90001-x.
7
Pharmacokinetics of oxprenolol in normal subjects.氧烯洛尔在正常受试者体内的药代动力学。
Clin Pharmacol Ther. 1976 Oct;20(4):401-12. doi: 10.1002/cpt1976204401.
Zotero 插件